FINHUB Insights

SYK · Q1 FY26 · Mar 31, 2026

Stryker Q1 FY26: where the revenue came from and where it went

Stryker Q1 FY26: revenue $6B (+3% year over year). Net profit $0.7B. Largest cohort Med Surg and Neurotechnology $3.2B. The whole income statement as a sankey diagram from the SEC filing.

Period
Mar 31, 2026
Reported
May 11, 2026 10-Q
Sankey diagram of Stryker's income statement for Q1 FY26: revenue of $6 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$6B +3% year over year
Gross profit$3.8B 63% margin
Operating profit$0.9B 16% margin
Net profit$0.7B 12% margin

The numbers

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Mar 31, 2026).
ItemValueShare of revenueYear over year
Revenue 6 100% +3%
Med Surg and Neurotechnology 3.2 53% +5%
Orthopaedics and Spine 2.8 47% +0%
Cost of revenue−2.237%
Gross profit3.863% margin−1pp
Research & development−0.47%+0pp
SG&A−2.338%−1pp
Other−0.23%+0pp
Operating profit0.916% margin+1pp
Tax−0.1
Interest & other costs−0.1
Net profit0.712%+1pp
Filing on EDGAR More quarters of SYK

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters